And the conversation has moved well past "does it work." People are now asking a bigger question: if a huge chunk of the ...

A new Medicare pilot program aims to expand access to GLP-1 weight loss medications, potentially reducing out-of-pocket costs ...

Roughly one in eight American adults is now taking a GLP-1 drug like Ozempic, Wegovy or Zepbound. The class traces back to a hormone isolated from Gila monster venom by a Bronx doctor who paid a ...

Serena Williams’ return to the tennis court, having dropped weight through GLP-1 drugs, has reignited the debate about the use of such substances in competitions. Helen Coffey looks into how they affe ...

New reports on GLP-1 drugs and the brain’s “wanting” system have direct implications for how leaders motivate, reward, build ...

Around 2 million people in the UK are estimated to use weight loss drugs, and nearly 80 per cent of them are women. But new ...

Novo Nordisk A/S outlook: 2026 guidance warns revenue/profit declines as GLP-1 competition, pricing pressure & patent risks ...

New ACP guidelines recommend semaglutide and tirzepatide as first-line medications for adults with obesity alongside ...

A new weight loss medication called retatrutide is drawing attention, though it hasn't yet been approved by the FDA.

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight. The reason why ...

Telehealth sprouted up with the COVID-19 pandemic and now it's spreading more, serving people seeking narrower waistlines ...